TRACLEER Side Effects

7024745-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Hepatic Congestion, Liver Function Test Abnormal, Respiratory Tract Infection
on Sep 16, 2010 Female patient from IRELAND , 76 years of age, weighting 110.2 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, hepatic congestion, liver function test abnormal, respiratory tract infection. Tracleer dosage: 125 Mg, Bid, Oral. During the same period patient was treated with SILDENAFIL CITRATE (View Sildenafil Citrate Review and Sildenafil Citrate Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MONTELUKAST (View Montelukast Review and Montelukast Label ), FLUTICASONE PROPIONATE W/SALMETEROL XINAFOATE (View Fluticasone Propionate W/salmeterol Xinafoate Review and Fluticasone Propionate W/salmeterol Xinafoate Label ). Patient was hospitalized.

7024744-0 | Contusion, Muscle Atrophy, Musculoskeletal Pain
Patient was taking Tracleer (View Usage). Patient had the following side effects: contusion, muscle atrophy, musculoskeletal pain on Sep 20, 2010 from SWEDEN Additional patient health information: Female patient , 66 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 125 Mg, Bid.

7024736-1 | Aortic Bypass, Aortic Valve Replacement, Cardiac Operation, Coronary Artery Bypass, Leg Amputation
Adverse event was reported on Sep 16, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: 62.5 Mg, Bid Oral, 125 Mg, Bid, Oral) was diagnosed with skin ulcer and. Location: GERMANY , 62 years of age, After Tracleer was administered, patient had the following side effects: aortic bypass, aortic valve replacement, cardiac operation, coronary artery bypass (What is coronary artery bypass?), leg amputation. Patient was hospitalized.

7024735-X | Hypertensive Crisis
on Sep 23, 2010 Female patient from GERMANY , 56 years of age, was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: hypertensive crisis. Tracleer dosage: 62.5 Mg, Oral.


7024733-6 | Arteriosclerosis Obliterans, Condition Aggravated, Dizziness, Scleroderma
on Sep 22, 2010 Female patient from JAPAN , 82 years of age, weighting 108.0 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: arteriosclerosis obliterans, condition aggravated, dizziness (What is dizziness?), scleroderma (What is scleroderma?). Tracleer dosage: 62.5 Mg, Bid, Oral; 62.5 Mg, Bid, Oral. During the same period patient was treated with BERAPROST SODIUM (BERAPROST SODIUM) (View Beraprost Sodium (beraprost Sodium) Review and Beraprost Sodium (beraprost Sodium) Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), TOCOPHERYL ACETATE (TOCOPHERYL ACETATE) (View Tocopheryl Acetate (tocopheryl Acetate) Review and Tocopheryl Acetate (tocopheryl Acetate) Label ), ASCORBIC ACID W/CALCIUM (ASCORBIC ACID, CALCIUM) (View Ascorbic Acid W/calcium (ascorbic Acid, Calcium) Review and Ascorbic Acid W/calcium (ascorbic Acid, Calcium) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LAFUTIDINE (LAFUTIDINE) (View Lafutidine (lafutidine) Review and Lafutidine (lafutidine) Label ), FEXOFENADINE HYDROCHLORIDE (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ). Patient was hospitalized.

7024728-2 | Disease Progression, Systemic Lupus Erythematosus
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: disease progression, systemic lupus erythematosus on Sep 22, 2010 from JAPAN Additional patient health information: Female patient , 36 years of age, weighting 138.9 lb, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 125 Mg, Bid, Oral; 62.5 Mg, Bid, Oral. During the same period patient was treated with BERAPROST SODIUM (BERAPROST SODIUM) (View Beraprost Sodium (beraprost Sodium) Review and Beraprost Sodium (beraprost Sodium) Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), SARPOGRELATE HYDROCHLORIDE (SARPROGRELATE HYDROCHLORIDE) (View Sarpogrelate Hydrochloride (sarprogrelate Hydrochloride) Review and Sarpogrelate Hydrochloride (sarprogrelate Hydrochloride) Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), ALFACALCIDOL (ALFACALCIDOL) (View Alfacalcidol (alfacalcidol) Review and Alfacalcidol (alfacalcidol) Label ), LAFUTIDINE (LAFUTIDINE) (View Lafutidine (lafutidine) Review and Lafutidine (lafutidine) Label ), ECABET MONOSODIUM (ECABET MONOSODIUM) (View Ecabet Monosodium (ecabet Monosodium) Review and Ecabet Monosodium (ecabet Monosodium) Label ). Patient was hospitalized.

7024181-9 | Abdominal Pain, Constipation, Gastroenteritis, Hypokalaemia, Nausea
Adverse event was reported on Sep 16, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: 125 Mg, Bid, Oral, 62.5 Mg, Bid, Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 43 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), constipation (What is constipation?), gastroenteritis (What is gastroenteritis?), hypokalaemia, nausea (What is nausea?). Patient was hospitalized.

7024153-4 | Oesophageal Cancer Metastatic
on Sep 15, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: oesophageal cancer metastatic. Tracleer dosage: Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ).

7024152-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Function Test Abnormal
on Sep 15, 2010 Male patient from UNITED STATES , 79 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal. Tracleer dosage: 62.5 Mg, Bid, Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ).

7024151-0 | Anaemia, Oedema, Pulmonary Oedema, Red Blood Cell Count Decreased, Swelling, Weight Increased
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, oedema, pulmonary oedema, red blood cell count decreased, swelling, weight increased on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Mg, Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

7024150-9 | Anaemia, Condition Aggravated, Dizziness, Dysgeusia, Dyspnoea, Fatigue, Flushing, Hypotension, Joint Swelling
Adverse event was reported on Sep 16, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 82 years of age, Patient had the following side effects: anaemia, condition aggravated, dizziness (What is dizziness?), dysgeusia, dyspnoea, fatigue, flushing, hypotension, joint swelling. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

7021627-7 | Acute Hepatic Failure, Pericardial Effusion
on Sep 13, 2010 Female patient from RUSSIAN FEDERATION , child 10 years of age, weighting 39.68 lb, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: acute hepatic failure, pericardial effusion. Tracleer dosage: 31.25 Mg, Qd, Oral. During the same period patient was treated with CAPOTEN (View Capoten Review and Capoten Label ).

7021626-5 | Metastases To Bone Marrow, Platelet Count Decreased
on Sep 15, 2010 Female patient from AUSTRALIA , 77 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: metastases to bone marrow, platelet count decreased. Tracleer dosage: 62.5 Mg, Bid, Oral.

7021625-3 |
Patient was taking Tracleer (View Usage). on Sep 15, 2010 from JAPAN Additional patient health information: Female patient , 87 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral.

7021624-1 | Condition Aggravated, Cor Pulmonale Acute, Duodenal Ulcer Haemorrhage, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Sep 12, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: ) was diagnosed with pulmonary arterial hypertension and. Location: AUSTRIA , 54 years of age, After Tracleer was administered, patient had the following side effects: condition aggravated, cor pulmonale acute, duodenal ulcer haemorrhage, upper gastrointestinal haemorrhage. Patient was hospitalized.

7021592-2 | Cholelithiasis, Dehydration, Dyspnoea, Gallbladder Pain, International Normalised Ratio Increased, Nausea, Pneumonia Aspiration, Pneumonitis, Pulmonary Alveolar Haemorrhage
on Sep 15, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: cholelithiasis, dehydration, dyspnoea, gallbladder pain, international normalised ratio increased, nausea (What is nausea?), pneumonia aspiration, pneumonitis, pulmonary alveolar haemorrhage. Tracleer dosage: Oral, 125 Mg, Bid, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

7021591-0 | Cough, Dyspnoea
on Sep 15, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: cough, dyspnoea. Tracleer dosage: Oral. During the same period patient was treated with VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

7021590-9 | Liver Disorder, Off Label Use, Stent Placement
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: liver disorder, off label use, stent placement on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 14 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

7021589-2 | Catheterisation Cardiac, Stent Placement
Adverse event was reported on Sep 13, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: catheterisation cardiac, stent placement. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), ACETYSALICYLIC ACID (View Acetysalicylic Acid Review and Acetysalicylic Acid Label ). Patient was hospitalized.

7021588-0 | Gait Disturbance, Neuropathy Peripheral, Pain
on Sep 13, 2010 Female patient from UNITED STATES , 79 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: gait disturbance, neuropathy peripheral, pain (What is pain?). Tracleer dosage: Oral.

7021587-9 | Oedema Peripheral, Off Label Use, Rectal Haemorrhage, Staphylococcal Infection, Urinary Tract Infection
on Sep 15, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: oedema peripheral, off label use, rectal haemorrhage, staphylococcal infection (What is staphylococcal infection?), urinary tract infection (What is urinary tract infection?). Tracleer dosage: Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), DIURETICS (View Diuretics Review and Diuretics Label ). Patient was hospitalized.

7021586-7 | Acute Respiratory Failure, Cholecystitis Acute, Cholelithiasis, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Gallbladder Disorder
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, cholecystitis acute, cholelithiasis, chronic obstructive pulmonary disease, condition aggravated, gallbladder disorder on Sep 14, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), SPIRIVA (TIOTROPIUM BROMIDEA) (View Spiriva (tiotropium Bromidea) Review and Spiriva (tiotropium Bromidea) Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), BRETHINE (View Brethine Review and Brethine Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

7020385-X | Pulmonary Embolism
Adverse event was reported on Sep 03, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 44 years of age, Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

7019299-0 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Disease Progression, Pulmonary Arterial Hypertension, Respiratory Failure
on Sep 09, 2010 Female patient from UNITED STATES , 84 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: chronic obstructive pulmonary disease, condition aggravated, disease progression, pulmonary arterial hypertension, respiratory failure. Tracleer dosage: Mg, Oral; 62 Mg, Bid, Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

7019298-9 | Liver Disorder, Liver Function Test Abnormal
on Sep 08, 2010 Female patient from UNITED STATES , 82 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, liver function test abnormal. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ). Patient was hospitalized.

7019263-1 | Cardiac Pacemaker Insertion, Eye Swelling, Joint Swelling, Oedema Peripheral, Swelling Face
Patient was taking Tracleer (View Usage). Patient had the following side effects: cardiac pacemaker insertion, eye swelling, joint swelling, oedema peripheral, swelling face on Sep 09, 2010 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 62.5 Mg, Bid, Oral. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

7019262-X | Arterial Occlusive Disease, Dyspnoea, Impaired Healing, Leg Amputation, Peripheral Vascular Disorder, Skin Graft, Skin Ulcer, Toe Amputation
Adverse event was reported on Sep 10, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 66 years of age, After Tracleer was administered, patient had the following side effects: arterial occlusive disease, dyspnoea, impaired healing, leg amputation, peripheral vascular disorder, skin graft, skin ulcer, toe amputation. Patient was hospitalized.

7019261-8 | Bronchitis, Urinary Tract Infection
on Sep 08, 2010 Female patient from UNITED STATES , 79 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), urinary tract infection (What is urinary tract infection?). Tracleer dosage: Oral. Patient was hospitalized.

7019257-6 |
on Sep 08, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). . Tracleer dosage: Oral. During the same period patient was treated with VENTAVIS (Respiratory) (View Ventavis Review and Ventavis Label ), COUMADIN (View Coumadin Review and Coumadin Label ).

7019256-4 | Cardiac Disorder, Off Label Use, Sleep Apnoea Syndrome, Supraventricular Tachycardia
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: cardiac disorder, off label use, sleep apnoea syndrome, supraventricular tachycardia on Sep 10, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

7019255-2 | Abnormal Loss Of Weight, Eating Disorder, Feeling Of Body Temperature Change, Intervertebral Disc Protrusion, Nerve Compression, Peripheral Coldness
Adverse event was reported on Sep 10, 2010 by a Male patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 75 years of age, Patient experienced the following unwanted or unexpected effects: abnormal loss of weight, eating disorder (What is eating disorder?), feeling of body temperature change, intervertebral disc protrusion, nerve compression, peripheral coldness. Patient was hospitalized.

7018353-7 | Back Pain
on Sep 14, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: back pain (What is back pain?). Tracleer dosage: Unk Oral. During the same period patient was treated with CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

7018350-1 | Abdominal Adhesions, Decreased Appetite, Diarrhoea, Gangrene, Nausea, Oedema Peripheral, Osteomyelitis, Small Intestinal Obstruction
on Sep 13, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: abdominal adhesions, decreased appetite, diarrhoea, gangrene, nausea (What is nausea?), oedema peripheral, osteomyelitis, small intestinal obstruction. Tracleer dosage: Unk Oral. Patient was hospitalized.

7018344-6 | Dyspnoea, Heat Stroke, Hyperchlorhydria, Sinusitis
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, heat stroke, hyperchlorhydria, sinusitis (What is sinusitis?) on Sep 13, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Unk Oral. Patient was hospitalized.

7018340-9 | Bacteraemia
Adverse event was reported on Sep 13, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Unk Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 48 years of age, Patient had the following side effects: bacteraemia. During the same period patient was treated with VENTAVIS (View Ventavis Review and Ventavis Label ), COUMADIN (View Coumadin Review and Coumadin Label ), VIAGRA (View Viagra Review and Viagra Label ). Patient was hospitalized.

7018334-3 | Fall, Joint Injury
on Sep 14, 2010 Female patient from UNITED STATES , 90 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: fall (What is fall?), joint injury. Tracleer dosage: Unk Oral. Patient was hospitalized.

7018332-X | Myocardial Infarction
on Sep 13, 2010 Male patient from UNITED STATES , 39 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Tracleer dosage: Unk Oral.

7018326-4 | Anaemia, Fall, Gastrointestinal Haemorrhage, Head Injury, Oedema, Pneumonia, Right Ventricular Failure
Patient was taking Tracleer (View Usage). Patient had the following side effects: anaemia, fall (What is fall?), gastrointestinal haemorrhage, head injury, oedema, pneumonia (What is pneumonia?), right ventricular failure on Sep 13, 2010 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Unk Oral. During the same period patient was treated with TADALAFIL (TADALAFIL) (View Tadalafil (tadalafil) Review and Tadalafil (tadalafil) Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ). Patient was hospitalized.

7018137-X | Ileus, Small Intestinal Obstruction
Adverse event was reported on Sep 09, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 77 years of age, After Tracleer was administered, patient had the following side effects: ileus, small intestinal obstruction. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

7018127-7 | Diarrhoea, Insomnia, Oedema, Oedema Peripheral, Pruritus, Pulmonary Oedema
on Sep 09, 2010 Female patient from UNITED STATES , 80 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, insomnia, oedema, oedema peripheral, pruritus, pulmonary oedema. Tracleer dosage: Oral. Patient was hospitalized.

7018117-4 | Anaemia, Blood Creatinine Increased, Blood Pressure Decreased, Dyspnoea, Lung Infection
on Sep 09, 2010 Female patient from UNITED STATES , 47 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: anaemia, blood creatinine increased, blood pressure decreased, dyspnoea, lung infection. Tracleer dosage: Oral. Patient was hospitalized.

7009141-6 | Cardiac Failure Congestive, Constipation, Fluid Overload, Gastroenteritis Viral, Haemoglobin Decreased, Malaise, Pain, Peripheral Ischaemia, Weight Increased
Patient was taking Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: cardiac failure congestive, constipation (What is constipation?), fluid overload, gastroenteritis viral, haemoglobin decreased, malaise, pain (What is pain?), peripheral ischaemia, weight increased on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 227.1 lb, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 125 Mg, Bid, Oral ; Oral. During the same period patient was treated with AGRYLIN (View Agrylin Review and Agrylin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), COMBIVENT (View Combivent Review and Combivent Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CHONDROITIN SULFATE (CHONDROITIN SULFATE) (View Chondroitin Sulfate (chondroitin Sulfate) Review and Chondroitin Sulfate (chondroitin Sulfate) Label ), GLUCOSAMINE (GLUCOSAMINE) (View Glucosamine (glucosamine) Review and Glucosamine (glucosamine) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

7008760-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Decreased Appetite, Liver Disorder, Malaise, Pyrexia
Adverse event was reported on Sep 07, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: 125 Mg, Bid, Oral; 62.5 Mg, Bid, Oral) was diagnosed with pulmonary arterial hypertension and. Location: JAPAN , 64 years of age, weighting 94.80 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, decreased appetite, liver disorder, malaise, pyrexia. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), WARFARIN POTASSIUM (WARFARIN POTASSIUM) (View Warfarin Potassium (warfarin Potassium) Review and Warfarin Potassium (warfarin Potassium) Label ), BERAPROST SODIUM (BERAPROST SODIUM) (View Beraprost Sodium (beraprost Sodium) Review and Beraprost Sodium (beraprost Sodium) Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ), ASPARTATE CALCIUM (ASPARTATE CALCIUM) (View Aspartate Calcium (aspartate Calcium) Review and Aspartate Calcium (aspartate Calcium) Label ), ALFACALCIDOL (ALFACALCIDOL) (View Alfacalcidol (alfacalcidol) Review and Alfacalcidol (alfacalcidol) Label ), REBAMIPIDE (REBAMIPIDE) (View Rebamipide (rebamipide) Review and Rebamipide (rebamipide) Label ). Patient was hospitalized.

7008759-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Liver Disorder
on Sep 09, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, liver disorder. Tracleer dosage: 125 Mg, Qd, Oral; Oral. During the same period patient was treated with WARFARIN POTASSIUM (WARFARIN POTASSIUM) (View Warfarin Potassium (warfarin Potassium) Review and Warfarin Potassium (warfarin Potassium) Label ), BERAPROST SODIUM (BERAPROST SODIUM) (View Beraprost Sodium (beraprost Sodium) Review and Beraprost Sodium (beraprost Sodium) Label ), OXYGEN (OXYGEN) (View Oxygen (oxygen) Review and Oxygen (oxygen) Label ). Patient was hospitalized.

7008758-2 |
on Sep 09, 2010 Female patient from CANADA , 63 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). . Tracleer dosage: .

7008748-X | Acute Respiratory Failure, Fall, Hip Fracture
Patient was taking Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure, fall (What is fall?), hip fracture on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: Oral. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized.

7008747-8 | Gastric Disorder
Adverse event was reported on Sep 10, 2010 by a Female patient taking Tracleer (View Usage) (Dosage: Oral) was diagnosed with pulmonary arterial hypertension and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: gastric disorder. During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ).

7008746-6 | Weight Increased
on Sep 08, 2010 Female patient from UNITED STATES , 81 years of age, was diagnosed with pulmonary arterial hypertension and was treated with Tracleer (View Usage). After Tracleer was administered, patient had the following side effects: weight increased. Tracleer dosage: 125 Mg, Bid, Oral. Patient was hospitalized.

7008706-5 | Biliary Sepsis, Liver Function Test Abnormal
on Sep 07, 2010 Male patient from GERMANY , 72 years of age, was diagnosed with systemic sclerosis and was treated with Tracleer (View Usage). Patient experienced the following unwanted or unexpected effects: biliary sepsis, liver function test abnormal. Tracleer dosage: 125 Mg, Bid; Oral. Patient was hospitalized.

7008705-3 | Pericardial Effusion, Pleural Effusion
Patient was taking Tracleer (View Usage). Patient had the following side effects: pericardial effusion, pleural effusion on Sep 09, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with pulmonary arterial hypertension and. Tracleer dosage: 62.5 Mg, Bid, Oral.